• +1 301 355 4647

Intellectual Property

Intellectual Property

The rapid multiplex pathogen diagnostic technology used by Shufflex Biomed was granted a patent by the United States Patent and Trademark Office (USPTO). Other patent application(s) have been filed worldwide.

Founded in 2015, Shufflex Biomed is headquartered in Germantown, Maryland, about 30 miles from Washington, DC and also based in Lower Johnsonville in Monrovia, Liberia, West Africa.

Pathogens we target

  • HIV
  • Ebola Virus
  • Marburg virus
  • Hepatitis C
  • Hepatitis B
  • Hepatitis E
  • SARS-CoV-1/2
  • MERS, Dengue virus
  • West Nile virus

Pathogens Con't

  • Zika
  • Plasmodium (Malaria)
  • Cytomegalovirus
  • Lassa Fever virus
  • Yellow Fever virus

Technologies

Features

Dr. Dougbeh Chris Nyan, M.D.

Inventor, Multiplex Pathogen Diagnostic Test

  • Biomedical research scientist; specializes in infectious disease diagnostics
  • Medical Degree: Charité-Medical Faculty; Humboldt-University of Berlin, Germany
  • Scientist/Fellow: US National Institutes of Health (NIH)
  • Scientist/Fellow: Laboratory of Emerging Pathogens, FDA
  • Scientist: Naval Medical Research Center
  • Scientist: BioReliance, Inc.
  • Research Fellow: University of Pennsylvania School of Medicine
  • Senior Scientist: Nabi Biopharmaceuticals Corp.
  • Testified before the US Congress on September 17, 2014 on the Ebola outbreak
  • Director: Diaspora Ebola Task Force
  • Member: International Society for Infectious Diseases (ISID)
  • Member: The European Society of Clinical Microbiology and Infectious Diseases (ESCMID)
  • Member: Data Safety Monitoring Board (DSMB), US-West African PREVAIL (Vaccine Trails)